Paul Fernyhough

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Oxidative Stress

Cardiovascular Disease

Endoplasmic Reticulum

Top Venues

Science advances

The Journal of pharmacology and experimental therapeutics

Antioxidants & redox signaling

Molecular neurobiology

University of Manitoba

University of Sheffield (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Manitoba Jun 01 2015

Canada

Head of Department :: Pharmacology & Therapeutics

Saint Boniface General Hospital Research Centre Feb 01 2004

Canada

Director :: Division of Neurodegenerative Disorders

University of Manitoba

Canada

Professor :: Pharmacology & Therapeutics

University of Manchester

United Kingdom

Lecturer (tenured) :: School of Biological Sciences

Queen Mary University of London

United Kingdom

MRC then Wellcome Trust Postdoctoral Fellow :: Pharmacology

Kings College London

United Kingdom

postdoctoral fellow :: MRC Cell Biophysics Unit

Colorado State University

United States

postdoctoral fellow :: Physiology

Education History

University of Sheffield

United Kingdom

PHD :: Biochemistry

University of Essex

United Kingdom

BSC :: Biological Sciences

Publications

Glen Lester Sequiera, Abhay Srivastava, Niketa Sareen, Weiang Yan, Keshav Narayan Alagarsamy, Elika Verma, Mohamad-Reza Aghanoori, Michel Aliani, Ashok Kumar, Paul Fernyhough, Cheryl Rockman-Greenberg, Sanjiv Dhingra
Development of iPSC-based clinical trial selection platform for patients with ultrarare diseases. Science advances 8 (14) (2022)
Farhana Naznin, T M Zaved Waise, Paul Fernyhough
Antagonism of the Muscarinic Acetylcholine Type 1 Receptor Enhances Mitochondrial Membrane Potential and Expression of Respiratory Chain Components via AMPK in Human Neuroblastoma SH-SY5Y Cells and Primary Neurons. Molecular neurobiology 59 (11) (2022)
Eftekhar Eftekharpour, Paul Fernyhough
Oxidative Stress and Mitochondrial Dysfunction Associated with Peripheral Neuropathy in Type 1 Diabetes. Antioxidants & redox signaling (2021)
Corinne G Jolivalt, Katie E Frizzi, May Madi Han, Andre J Mota, Lucie S Guernsey, Lakshmi P Kotra, Paul Fernyhough, Nigel A Calcutt
Topical Delivery of Muscarinic Receptor Antagonists Prevents and Reverses Peripheral Neuropathy in Female Diabetic Mice. The Journal of pharmacology and experimental therapeutics 374 (1) (2020)